FilingSEC EDGAR6-K
Clearmind Medicine Enrolls First Patients in CMND-100 Clinical Trial
· SEC accepted
Filing content
Clearmind Medicine enrolled the first patients in its clinical trial for CMND-100, a treatment candidate for alcohol use disorder. The trial will evaluate the safety and efficacy of the candidate.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…